Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Winter

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
British Journal of Haematology|February 10, 2022
Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphomaIshan Roy, Gordon Smilnak, Madelyn Burkart, et al.
Psycho-Oncology|November 3, 2017
Social support following diagnosis and treatment for colorectal cancer and associations with health-related quality of life: Results from the UK ColoREctal Wellbeing (CREW) cohort studyJoanne Haviland, Samantha Sodergren, Lynn Calman, et al.
Plos One|April 10, 2020
Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) studySally Wheelwright, Natalia V Permyakova, Lynn Calman, et al.
BMJ Open|November 13, 2020
Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal studyJane Frankland, Sally Wheelwright, Natalia V Permyakova, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 22, 2021
Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) studyLynn Calman, Joshua Turner, Deborah Fenlon, et al.
European Journal of Cancer Care|August 23, 2021
Unmet supportive care needs of breast, colorectal and testicular cancer survivors in the first 8 months post primary treatment: A prospective longitudinal surveyLynn Batehup, Heather Gage, Peter Williams, et al.
Psycho-Oncology|August 3, 2018
Comorbidities are associated with poorer quality of life and functioning and worse symptoms in the 5 years following colorectal cancer surgery: Results from the ColoREctal Well-being (CREW) cohort studyAmanda Cummings, Chloe Grimmett, Lynn Calman, et al.
BMC Medical Research Methodology|December 31, 2013
Lessons learnt recruiting to a multi-site UK cohort study to explore recovery of health and well-being after colorectal cancer (CREW study)Deborah Fenlon, Kim Chivers Seymour, Ikumi Okamoto, et al.
Cancer|March 14, 2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipientsSteve Trifilio, Gennethel Pennick, Judy Pi, et al.
Plos One|May 13, 2016
Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort StudyClaire Foster, Joanne Haviland, Jane Winter, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|February 10, 2022
Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphomaIshan Roy, Gordon Smilnak, Madelyn Burkart, et al.
Psycho-Oncology|November 3, 2017
Social support following diagnosis and treatment for colorectal cancer and associations with health-related quality of life: Results from the UK ColoREctal Wellbeing (CREW) cohort studyJoanne Haviland, Samantha Sodergren, Lynn Calman, et al.
Plos One|April 10, 2020
Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) studySally Wheelwright, Natalia V Permyakova, Lynn Calman, et al.
BMJ Open|November 13, 2020
Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal studyJane Frankland, Sally Wheelwright, Natalia V Permyakova, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 22, 2021
Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) studyLynn Calman, Joshua Turner, Deborah Fenlon, et al.
European Journal of Cancer Care|August 23, 2021
Unmet supportive care needs of breast, colorectal and testicular cancer survivors in the first 8 months post primary treatment: A prospective longitudinal surveyLynn Batehup, Heather Gage, Peter Williams, et al.
Psycho-Oncology|August 3, 2018
Comorbidities are associated with poorer quality of life and functioning and worse symptoms in the 5 years following colorectal cancer surgery: Results from the ColoREctal Well-being (CREW) cohort studyAmanda Cummings, Chloe Grimmett, Lynn Calman, et al.
BMC Medical Research Methodology|December 31, 2013
Lessons learnt recruiting to a multi-site UK cohort study to explore recovery of health and well-being after colorectal cancer (CREW study)Deborah Fenlon, Kim Chivers Seymour, Ikumi Okamoto, et al.
Cancer|March 14, 2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipientsSteve Trifilio, Gennethel Pennick, Judy Pi, et al.
Plos One|May 13, 2016
Pre-Surgery Depression and Confidence to Manage Problems Predict Recovery Trajectories of Health and Wellbeing in the First Two Years following Colorectal Cancer: Results from the CREW Cohort StudyClaire Foster, Joanne Haviland, Jane Winter, et al.
Pageof 3